Home Diagnostic Devices

Diagnostic Devices

Diagnostic Devices Market Intelligence

Diagnostics are no longer just a supporting act, they are now driving the future of precision healthcare. From advanced MRI systems unveiling early stage pathologies to rapid POCT bringing critical care to the bedside or the home, and next generation IVD enabling targeted treatments, diagnostic technologies are reshaping clinical pathways.

Global demand for timely, accurate, and affordable diagnostics is being amplified by trends such as:

  • Rising burden of chronic and infectious diseases

  • Shift toward decentralized and preventive care

  • Digital transformation of healthcare systems

  • AI’s growing role in image based and molecular diagnostics

  • Push for faster diagnosis to enable faster therapeutic interventions

At the same time, diagnostic markets face pricing pressures, stringent regulations, fragmented value chains, and the urgent need for interoperability.

Where We Add Value: We go beyond standard market sizing, we identify emerging white spaces, track evolving clinical demand, and help our clients anticipate shifts in reimbursement, technology adoption, and purchasing behavior, so they can make faster, smarter market moves. Our insights decode these complexities across the diagnostic devices value chain from product innovation to market adoption helping clients:

  • Prioritize investments
  • Anticipate regulatory shifts
  • Track new revenue streams (POCT, AI driven imaging, at home testing)
  • Benchmark their competitive edge in fast evolving markets

Topics Covered

In Vitro Diagnostics (IVD)
  • The global market size for in vitro diagnostics market is USD 82.98 Billion in 2024 and is projected to reach the value of USD 100.43 Billion in 2028 at a notable CAGR of 5.10%.
  • IVD is undergoing a transformation, powered by next generation molecular diagnostics, rapid point-of-care testing, and AI driven interpretation engines.
  • There is a clear shift toward personalized testing, syndromic panels, and home use diagnostics, particularly in oncology, infectious disease, and genetic screening.
  • The global market size for magnetic resonance imaging systems market is USD 7.0 billion in 2024 and is projected to reach the value of USD 8.4 billion in 2028 at a notable CAGR of 4.6%.
  • The MRI market is expanding with AI augmented image reconstruction, portable MRI devices, and low field systems making advanced imaging more accessible.
  • Increased use in neurology, oncology, and musculoskeletal applications, combined with faster scanning protocols and lower operating costs, are driving wider adoption beyond large hospital settings.
  • The endoscopy devices market is anticipated to witness significant growth during the forecast timeframe. With rising demand for early cancer screening (GI, lung), and a sharp focus on infection control, the market is moving toward robotic assisted systems, AI enhanced visualization, and single use endoscopes.
  • Reimbursement clarity and faster regulatory pathways are further accelerating adoption across both developed and emerging markets.
  • The global push toward decentralized and consumer led healthcare is fueling POC growth across chronic disease management, infectious disease, and cardiac care.
  • Retail health expansion, integration with digital health platforms, and increasing penetration of AI based POC analyzers are shaping the future of this segment.

What you unlock in the Diagnostic Devices Cluster

Whether you are launching disruptive diagnostic platforms, unlocking new reimbursement pathways, or staying ahead in the fast evolving imaging and POCT space, we help you turn data into decisive action.

Market Intelligence Hub

Market Intelligence Hub

Holistic market mapping across MRI, IVD, Endoscopy Devices, POCT; market sizing, growth hotspots, regulatory outlooks, innovation trends.

Forecast Dashboard

Forecast Dashboard

  • 8 year market revenue visualizations (4 years historical + 4 years forecast)
  • Global revenues categorized by region and country level analysis.
Country Level Analysis

Country Level Analysis

Tailored analysis of each country’s market landscape, highlighting trends, growth levers, roadblocks, and fresh developments.

Emerging Trend Radar

Emerging Trend Radar

Stay ahead of the curve with detailed insights on:
  • Preventive Diagnostics in Action: Redefining European Healthcare with In Vitro Diagnostics
  • Decentralizing Diagnosis: Scaling Access with WHO’s Prequalification & POCT
  • MRI 2033: Navigating the Next Wave of Imaging Innovation
  • Magnetic Momentum: How Europe’s MRI Usage Signals Market Expansion
  • Digital endoscopy and AI integration trends
  • Decentralized testing in retail clinics & home based POCT surge
  • Companion diagnostics for oncology & rare diseases

And many more additions coming your way, driven by emerging trends designed to accelerate your business from every angle!

Market Intelligence Hub

Company Briefing

Detailed analysis of leading and emerging players in the space!

Segmental Analysis

Segmental Analysis

Combines in-depth data and strategic narratives across countries and regions, tailored to every segment we cover.

Sources & Citations

Sources & Citations

Every data point, forecast or qualitative insights is backed by credible primary and secondary sources and shall be provided for validation.

Company Market Share Analysis

Company Market Share Analysis

Quantitative assessment of market shares by revenues at the global OR regional level

KOL + Payer Insights

KOL + Payer Insights

  • What do experts really think?
  • Transcripts of real world interviews with clinicians, OEMs, regulators, radiologists, lab directors, surgeons, procurement heads etc.
In the News Trending Insights Strip

In the News” or Trending Insights Strip

Recent news and rolling updates on diagnostics innovations, M&A, approvals, and policies.

What’s coming next?

Clinical trials efficacy rate analysis for individual trials across the medical device categories

In-depth pricing insights for diagnostic devices available in the market

Diagnostic Devices Industry Value Chain

Decoding the Market Pulse: Key Market Indicators We Analyzed to Map the Momentum

Indicators What It Tells Us
Volume trends of tests, scans, procedures (by country) We track procedure volumes to identify real world demand growth by country and specialty.
Import/export flows of diagnostic devices & components We track global trade flows to spot supply chain shifts, trade risks, and emerging sourcing trends.
Pipeline of diagnostic innovations, new platforms, AI tools, etc. We track the innovation pipeline to identify future market disruptors and emerging technology trends.
AI integration in diagnostic workflows We track emerging use cases, adoption rates, and regulatory traction across MRI, IVD, Endoscopy etc.
Shifts in procurement models (capex vs opex, leasing trends) We evaluate the demand for leasing, pay per use, and subscription models for capital equipment like MRI.
Adoption of home based and decentralized diagnostics We track how demand is shifting toward POCT and at home diagnostics to assess market potential.
Changes in reimbursement frameworks for advanced diagnostics We track reimbursement shifts to understand payer appetite and likely adoption trends for new diagnostics.
OEM partnerships with digital health & AI vendors We track ecosystem partnerships to identify emerging business models and technology integrations.
Public sector tenders & procurement trends We track public sector spending patterns to uncover new market opportunities in emerging regions.
Hospital & diagnostic chain consolidation We track market consolidation to assess impacts on pricing dynamics, procurement behavior, and innovation cycles.
Clinical guideline updates impacting diagnostic pathways We track clinical guidelines to forecast shifts in diagnostic demand and usage trends.
Installed base and replacement cycles (MRI & capital equipment) We track installed base and replacement demand to project upcoming purchase cycles and market opportunities.

Before First IQ

  • You're struggling to find reliable market research, wasting time and resources on incomplete data.
  • Your business decisions are based on assumptions, not facts, putting your company at risk.
  • You're falling behind competitors who have access to better insights.

Bridge:

  • First IQ is the connection between uncertainty and confidence, between assumptions and facts.
  • Our platform bridges the gap between data and insights, providing a clear understanding of your market.
  • With First IQ, you can transition from uncertainty to clarity, unlocking your business's true potential.

After First IQ

  • With First IQ, you have instant access to comprehensive market research, empowering informed decisions.
  • You're equipped with actionable insights, identifying new opportunities and staying ahead of industry trends.
  • Your business thrives, outpacing competitors and achieving its full potential.

Features